An updated meta-analysis that included the NICE-SUGAR results again found a six-fold increased risk of severe hypoglycemia among patients given intensive insulin therapy compared with controls, with little examination of the protocols represented [14]. The gene discussed is INS; the disease is Hypoglycemia.